$WYY
WIDEPOINT CORP Stock $wyy

$wyy Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000165495422015266 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$23.34M	$25.27M	$22.25M
YoY Change	-4.56%	13.57%	-61.31%
Cost Of Revenue	$19.78M	$21.47M	$18.59M
YoY Change	-3.31%	15.51%	-64.18%
Gross Profit	$3.560M	$3.799M	$3.663M
YoY Change	-10.93%	3.72%	-34.8%
Gross Profit Margin	15.25%	15.03%	16.46%
Selling, General & Admin	$4.032M	$4.123M	$2.591M
YoY Change	-11.42%	59.13%	-38.08%
% of Gross Profit	113.26%	108.51%	70.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$763.1K	$272.2K	$263.2K
YoY Change	47.45%	3.42%	-7.71%
% of Gross Profit	21.44%	7.16%	7.19%
Operating Expenses	$4.298M	$4.395M	$2.854M
YoY Change	-10.64%	54.0%	-36.15%
Operating Profit	-$738.7K	-$595.6K	$809.0K
YoY Change	-9.22%	-173.62%	-29.58%
Interest Expense	-$45.75K	$62.84K	$67.37K
YoY Change	-29.54%	-6.73%	-3.18%
% of Operating Profit			8.33%
Other Income/Expense, Net	$380.1K	-$63.44K	-$41.25K
YoY Change	-38.23%	53.81%	-40.54%
Pretax Income	-$404.3K	-$659.1K	$767.8K
YoY Change	53.56%	-185.84%	-28.87%
Income Tax	$8.488M	$659.1K	$232.9K
% Of Pretax Income			30.33%
Net Earnings	-$8.892M	-$540.9K	$534.9K
YoY Change	1447.89%	-201.12%	-49.87%
Net Earnings / Revenue	-38.1%	-2.14%	2.4%
Basic Earnings Per Share		-$0.06	$0.06
Diluted Earnings Per Share	-$1.02	-$0.06	$0.06
COMMON SHARES
Basic Shares Outstanding	8.725M shares	8.734M shares	9.129M shares
Diluted Shares Outstanding		8.725M shares	9.158M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.531M	$5.061M	$18.10M
YoY Change	16.22%	-72.04%	59.17%
Cash & Equivalents	$7.531M	$5.061M	$18.10M
Short-Term Investments
Other Short-Term Assets	$936.0K	$2.928M	$3.721M
YoY Change	-70.7%	-21.32%	110.99%
Inventory	$222.3K	$541.8K	$1.199M
Prepaid Expenses
Receivables	$9.277M	$13.56M	$12.54M
Other Receivables	$0.00	$1.144M	$1.296M
Total Short-Term Assets	$27.99M	$28.57M	$40.76M
YoY Change	-15.57%	-29.9%	-39.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$978.2K	$1.063M	$833.6K
YoY Change	16.3%	27.48%	45.47%
Goodwill	$5.812M	$5.812M	$18.56M
YoY Change	-73.69%	-68.68%	0.0%
Intangibles	$7.398M	$6.638M	$2.588M
YoY Change	18.77%	156.47%	18.31%
Long-Term Investments
YoY Change
Other Assets	$2.026M	$2.932M	$1.504M
YoY Change	13.68%	94.94%	84.55%
Total Long-Term Assets	$21.02M	$29.63M	$34.67M
YoY Change	-50.34%	-14.55%	2.48%
TOTAL ASSETS
Total Short-Term Assets	$27.99M	$28.57M	$40.76M
Total Long-Term Assets	$21.02M	$29.63M	$34.67M
Total Assets	$49.01M	$58.20M	$75.43M
YoY Change	-35.07%	-22.85%	-25.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.52M	$15.10M	$10.80M
YoY Change	21.94%	39.88%	-70.19%
Accrued Expenses	$11.33M	$8.548M	$11.20M
YoY Change	-8.24%	-23.69%	-28.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.14M	$26.23M	$26.12M
YoY Change	0.4%	0.42%	-52.02%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.118M	$5.618M	$246.0K
YoY Change	-34.16%	2183.47%
Total Long-Term Liabilities	$5.118M	$5.618M	$246.0K
YoY Change	-34.16%	2183.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.14M	$26.23M	$26.12M
Total Long-Term Liabilities	$5.118M	$5.618M	$246.0K
Total Liabilities	$31.26M	$31.85M	$32.28M
YoY Change	-7.55%	-1.33%	-46.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$83.10M	-$74.21M	-$58.94M
YoY Change	39.63%	25.9%	-1.53%
Common Stock	$101.2M	$8.726K	$102.3M
YoY Change	-0.23%	-99.99%	1.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.75M	$26.35M	$43.15M
YoY Change
Total Liabilities & Shareholders Equity	$49.01M	$58.20M	$75.43M
YoY Change	-35.07%	-22.85%	-25.55%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$8.892M	-$540.9K	$534.9K
YoY Change	1447.89%	-201.12%	-49.87%
Depreciation, Depletion And Amortization	$763.1K	$272.2K	$263.2K
YoY Change	47.45%	3.42%	-7.71%
Cash From Operating Activities	$2.851M	-$962.5K	$3.871M
YoY Change	-160.88%	-124.86%	-11.31%
INVESTING ACTIVITIES
Capital Expenditures	$345.6K	-$912.3K	-$689.5K
YoY Change	-142.38%	32.32%	134.51%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$345.6K	-$912.3K	-$689.5K
YoY Change	-93.72%	32.32%	134.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-153.7K	-149.6K	26.36K
YoY Change	-88.91%	-667.37%	-109.0%
NET CHANGE
Cash From Operating Activities	2.851M	-962.5K	3.871M
Cash From Investing Activities	-345.6K	-912.3K	-689.5K
Cash From Financing Activities	-153.7K	-149.6K	26.36K
Net Change In Cash	2.352M	-2.024M	3.208M
YoY Change	-120.32%	-163.1%	-15.08%
FREE CASH FLOW
Cash From Operating Activities	$2.851M	-$962.5K	$3.871M
Capital Expenditures	$345.6K	-$912.3K	-$689.5K
Free Cash Flow	$2.505M	-$50.15K	$4.561M
YoY Change	-164.78%	-101.1%	-2.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001034760
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2045714	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8842026	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8725476	shares
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	246000	usd
CY2021Q4	wyy	Warrants Issued Exercisable Term WarrantsIssuedExercisableTerm	four years
	us-gaap	Share Based Compensation ShareBasedCompensation	384267	usd
CY2022Q2	wyy	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Warrants Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWarrantsSettlements	0	usd
CY2022Q2	us-gaap	Goodwill Goodwill	5811578	usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	16300000.0	usd
CY2022Q3	wyy	Common Stock Par Value Per Share CommonStockParValuePerShare	1
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33035
	dei	Entity Registrant Name EntityRegistrantName	WidePoint Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2040275
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11250 Waples Mill Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	South Tower 210
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fairfax
	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	22030
	dei	City Area Code CityAreaCode	703
	dei	Local Phone Number LocalPhoneNumber	349-2577
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	WYY
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8725476	shares
CY2022Q3	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	366885	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	133756	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	961341	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	373089	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	3663014	usd
	us-gaap	Gross Profit GrossProfit	11015821	usd
	us-gaap	Gross Profit GrossProfit	12371154	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	489721	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1665518	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1505548	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	115141	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	235469	usd
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	263192	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	810652	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	662132	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11157690	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8676332	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16277000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	272203	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	767940	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4395074	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2853996	usd
	us-gaap	Operating Expenses OperatingExpenses	29910860	usd
	us-gaap	Operating Expenses OperatingExpenses	10949820	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-595622	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	809018	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18895039	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1421334	usd
CY2022Q3	us-gaap	Noninterest Income NoninterestIncome	6398	usd
CY2021Q3	us-gaap	Noninterest Income NoninterestIncome	968	usd
	us-gaap	Noninterest Income NoninterestIncome	17126	usd
	us-gaap	Noninterest Income NoninterestIncome	3535	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	62841	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	67372	usd
	us-gaap	Interest Expense InterestExpense	189188	usd
	us-gaap	Interest Expense InterestExpense	207678	usd
CY2022Q3	wyy	Other Expense Income OtherExpenseIncome	-6999	usd
CY2021Q3	wyy	Other Expense Income OtherExpenseIncome	25158	usd
	wyy	Other Expense Income OtherExpenseIncome	964004	usd
	wyy	Other Expense Income OtherExpenseIncome	27656	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41246	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	791942	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-176487	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	659064	usd
CY2022Q3	wyy	Income Tax Benefit Provision IncomeTaxBenefitProvision	118181	usd
CY2021Q3	wyy	Income Tax Benefit Provision IncomeTaxBenefitProvision	-232888	usd
	wyy	Income Tax Benefit Provision IncomeTaxBenefitProvision	3410108	usd
	wyy	Income Tax Benefit Provision IncomeTaxBenefitProvision	-329270	usd
CY2022Q3	wyy	Net Income Losses NetIncomeLosses	-540883	usd
CY2021Q3	wyy	Net Income Losses NetIncomeLosses	534884	usd
	wyy	Net Income Losses NetIncomeLosses	-14692989	usd
	wyy	Net Income Losses NetIncomeLosses	915577	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8725476	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9129406	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8734471	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9066088	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8725476	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9158396	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8734471	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9182190	shares
CY2022Q3	wyy	Net Income Losses NetIncomeLosses	-540883	usd
CY2021Q3	wyy	Net Income Losses NetIncomeLosses	534884	usd
	wyy	Net Income Losses NetIncomeLosses	-14692989	usd
	wyy	Net Income Losses NetIncomeLosses	915577	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-118524	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-49979	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-258213	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-85295	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-118524	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-49979	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-258213	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-85295	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-659407	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	484905	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14951202	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	830282	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5061320	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6479980	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	41313	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	62988	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13559112	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12536584	usd
CY2022Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	7024861	usd
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	10937415	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2927804	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3194009	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	28573097	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	33147988	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1062614	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	841133	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4892349	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6273211	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6637747	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6228886	usd
CY2022Q3	us-gaap	Goodwill Goodwill	5811578	usd
CY2021Q4	us-gaap	Goodwill Goodwill	22088578	usd
CY2022Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	8289372	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5127482	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2931994	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1782060	usd
CY2022Q3	us-gaap	Assets Assets	58198751	usd
CY2021Q4	us-gaap	Assets Assets	75489338	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	15103368	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10263015	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8548396	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12344426	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1934162	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2280894	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	645019	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	794175	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	358000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	26230945	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26040510	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4860381	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6025691	usd
CY2022Q3	wyy	Contingent Consideration Non Current ContingentConsiderationNonCurrent	387000	usd
CY2021Q4	wyy	Contingent Consideration Non Current ContingentConsiderationNonCurrent	1347000	usd
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	370800	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	400142	usd
CY2022Q3	us-gaap	Liabilities Liabilities	31849126	usd
CY2021Q4	us-gaap	Liabilities Liabilities	33813343	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2045714	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8725476	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8842026	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	8726	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	8842	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	101049870	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	101424922	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-499799	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-241586	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74209172	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59516183	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	26349625	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41675995	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58198751	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	75489338	usd
	us-gaap	Profit Loss ProfitLoss	-14692989	usd
	us-gaap	Profit Loss ProfitLoss	915577	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3176568	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-20150	usd
	us-gaap	Depreciation Depreciation	813624	usd
	us-gaap	Depreciation Depreciation	767856	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16277000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	244	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-24544	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	958369	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	373089	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	384267	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	662132	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	108000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	0	usd
	wyy	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-960000	usd
	wyy	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	usd
	wyy	Increase Decrease In Accounts Receivable And Unbilled Accounts Receivable IncreaseDecreaseInAccountsReceivableAndUnbilledAccountsReceivable	2804675	usd
	wyy	Increase Decrease In Accounts Receivable And Unbilled Accounts Receivable IncreaseDecreaseInAccountsReceivableAndUnbilledAccountsReceivable	30807310	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	47618	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-207823	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	209399	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1755636	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	27966	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	27161	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1080368	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-30169455	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7600	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	272523	usd
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-314226	usd
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	1566000	usd
	wyy	Increase Decrease In Other Liability IncreaseDecreaseInOtherLiability	-358000	usd
	wyy	Increase Decrease In Other Liability IncreaseDecreaseInOtherLiability	246037	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3217347	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3460077	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	239233	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	163031	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2823887	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1776382	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1939413	usd
	wyy	Advances On Bank Line Of Credit AdvancesOnBankLineOfCredit	4455523	usd
	wyy	Advances On Bank Line Of Credit AdvancesOnBankLineOfCredit	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	428415	usd
	wyy	Withholding Taxes Paid On Behalf Of Employees On Net Settled Restricted Stock Awards WithholdingTaxesPaidOnBehalfOfEmployeesOnNetSettledRestrictedStockAwards	-140865	usd
	wyy	Common Stock Repurchased CommonStockRepurchased	0	usd
	wyy	Issuance Of Common Stock At The Market Offering Net Of Issuance Costs IssuanceOfCommonStockAtTheMarketOfferingNetOfIssuanceCosts	0	usd
	wyy	Issuance Of Common Stock At The Market Offering Net Of Issuance Costs IssuanceOfCommonStockAtTheMarketOfferingNetOfIssuanceCosts	1071045	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	179273	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1314126	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	681038	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-258761	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-96110	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1418660	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2105592	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6479980	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15996749	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5061320	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18102341	usd
	us-gaap	Interest Paid Net InterestPaidNet	141924	usd
	us-gaap	Interest Paid Net InterestPaidNet	207613	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	27559	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	186063	usd
	wyy	Capitalized Hardware And Software Development Costs In Accounts Payable Mgkhg CapitalizedHardwareAndSoftwareDevelopmentCostsInAccountsPayableMgkhg	90854	usd
	wyy	Capitalized Hardware And Software Development Costs In Accounts Payable Mgkhg CapitalizedHardwareAndSoftwareDevelopmentCostsInAccountsPayableMgkhg	75558	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	876281	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	40551723	usd
CY2021Q1	wyy	Issuance Of Common Stock Options Exercises Shares IssuanceOfCommonStockOptionsExercisesShares	2500	shares
CY2021Q1	wyy	Issuance Of Common Stock Options Exercises Amount IssuanceOfCommonStockOptionsExercisesAmount	10250	usd
CY2021Q1	wyy	Issuance Of Common Stock Restricted Shares IssuanceOfCommonStockRestrictedShares	91650	shares
CY2021Q1	wyy	Issuance Of Common Stock Restricted Amount IssuanceOfCommonStockRestrictedAmount	-140894	usd
CY2021Q1	wyy	Issuance Of Common Stock Through At The Market Offering Program Net Of Issuance Costs Of333305 Shares IssuanceOfCommonStockThroughAtTheMarketOfferingProgramNetOfIssuanceCostsOf333305Shares	100687	shares
CY2021Q1	wyy	Issuance Of Common Stock Through At The Market Offering Program Net Of Issuance Costs Of333305 Amount IssuanceOfCommonStockThroughAtTheMarketOfferingProgramNetOfIssuanceCostsOf333305Amount	1088398	usd
CY2021Q1	wyy	Share Based Compensation Expense Restricted ShareBasedCompensationExpenseRestricted	157107	usd
CY2021Q1	wyy	Non Qualified Stock Options NonQualifiedStockOptions	25735	usd
CY2021Q1	wyy	Loss loss	-54949	usd
CY2021Q1	wyy	Net Income NetIncome	585424	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	42222794	usd
CY2021Q2	wyy	Issuance Of Common Stock Options Exercises Shares IssuanceOfCommonStockOptionsExercisesShares	28208	shares
CY2021Q2	wyy	Issuance Of Common Stock Options Exercises Amount IssuanceOfCommonStockOptionsExercisesAmount	0	usd
CY2021Q2	wyy	Share Based Compensation Expense Restricted ShareBasedCompensationExpenseRestricted	214852	usd
CY2021Q2	wyy	Share Based Compensation Expense Non Qualified Stock Options ShareBasedCompensationExpenseNonQualifiedStockOptions	28969	usd
CY2021Q2	wyy	Offering Costs For The Issuance Of Common Stock At The Market Offering OfferingCostsForTheIssuanceOfCommonStockAtTheMarketOffering	-17324	usd
CY2021Q2	wyy	Foreign Currency Translation Gain ForeignCurrencyTranslationGain	19633	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-204731	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	42264193	usd
CY2021Q3	wyy	Issuance Of Common Stock Restricted Options Exercises Amount IssuanceOfCommonStockRestrictedOptionsExercisesAmount	169023	usd
CY2021Q3	wyy	Share Based Compensation Expense Restricted ShareBasedCompensationExpenseRestricted	210602	usd
CY2021Q3	wyy	Share Based Compensation Expense Non Qualified Stock Options ShareBasedCompensationExpenseNonQualifiedStockOptions	24867	usd
CY2021Q3	wyy	Foreign Currency Translation Gain ForeignCurrencyTranslationGain	-49979	usd
CY2021Q3	wyy	Net Income NetIncome	534884	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	43153590	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41675995	usd
CY2022Q1	wyy	Common Stock Repurchased Shares CommonStockRepurchasedShares	-818211	usd
CY2022Q1	wyy	Issuance Of Common Stock Restricted Amount IssuanceOfCommonStockRestrictedAmount	-49224	usd
CY2022Q1	wyy	Issuance Of Common Stock Warrants IssuanceOfCommonStockWarrants	108000	usd
CY2022Q1	wyy	Share Based Compensation Expense Restricted ShareBasedCompensationExpenseRestricted	179741	usd
CY2022Q1	wyy	Foreign Currency Translation Loss ForeignCurrencyTranslationLoss	-4835	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-392897	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	40698569	usd
CY2022Q2	wyy	Issuance Of Common Stock Restricted Amount IssuanceOfCommonStockRestrictedAmount	0	usd
CY2022Q2	wyy	Share Based Compensation Expense Restricted ShareBasedCompensationExpenseRestricted	89385	usd
CY2022Q2	wyy	Foreign Currency Translation Loss ForeignCurrencyTranslationLoss	-134854	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-13759209	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	26893891	usd
CY2022Q3	wyy	Share Based Compensation Expense Restricted ShareBasedCompensationExpenseRestricted	115141	usd
CY2022Q3	wyy	Foreign Currency Translation Loss ForeignCurrencyTranslationLoss	-118524	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-540883	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	26349625	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	246000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring use of estimates and judgment relate to revenue recognition, accounts receivable valuation reserves, ability to realize intangible assets and goodwill, ability to realize deferred income tax assets, fair value of certain financial instruments and the evaluation of contingencies and litigation. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates. There were no significant changes in accounting estimates used by management during the quarter, except for the goodwill impairment adjustment discussed below. </p>
	wyy	Significant Accounting Policies SignificantAccountingPolicies	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">There were no significant changes in the Company’s significant accounting policies during the first nine months of 2022 from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 28, 2022.</p>
	wyy	Accounting Standards Under Evaluationpolicytextblock AccountingStandardsUnderEvaluationpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:left;">In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): <em>Measurement of Credit Losses on Financial Instruments</em>” (“Topic 326”). Topic 326 amends guidance on reporting credit losses for assets held at amortized cost basis and available for sale debt securities. For assets held at amortized cost basis, Topic 326 eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected. For available for sale debt securities, credit losses should be measured in a manner similar to current GAAP, however Topic 326 will require that credit losses be presented as an allowance rather than as a write-down. This ASU update affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. This update is effective for the company for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact of the pending adoption of this new standard on its consolidated financial statements.</p>
CY2021Q4	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4750000	usd
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	75000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.33
	wyy	Warrants Issued During Period Shares WarrantsIssuedDuringPeriodShares	75000	shares
	wyy	Contingent Consideration Paid Cash ContingentConsiderationPaidCash	250000	usd
CY2022Q3	wyy	Contingent Consideration Warrants ContingentConsiderationWarrants	0	usd
CY2022Q3	wyy	Contingent Consideration Cash Settled Net Of Current Portion ContingentConsiderationCashSettledNetOfCurrentPortion	56000	usd
CY2022Q3	wyy	Contingent Consideration Warrants Net Of Current Portion ContingentConsiderationWarrantsNetOfCurrentPortion	31000	usd
CY2022Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	387000	usd
CY2021Q4	wyy	Contingent Consideration Cash Settled ContingentConsiderationCashSettled	250000	usd
CY2021Q4	wyy	Contingent Consideration Warrants ContingentConsiderationWarrants	108000	usd
CY2021Q4	wyy	Contingent Consideration Cash Settled Net Of Current Portion ContingentConsiderationCashSettledNetOfCurrentPortion	1095000	usd
CY2021Q4	wyy	Contingent Consideration Warrants Net Of Current Portion ContingentConsiderationWarrantsNetOfCurrentPortion	252000	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1705000	usd
	wyy	Fair Value Of Contingent Consideration Table Textblock FairValueOfContingentConsiderationTableTextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Contingent consideration, December 31, 2021</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>1,705,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="TEXT-INDENT: 15px;vertical-align:top;">Change in fair value (gain) reported in the consolidated statement of operations</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(301,000</strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td style="TEXT-INDENT: 15px;vertical-align:top;">Contingent consideration settled - cash</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(171,000</strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td style="TEXT-INDENT: 15px;vertical-align:top;">Contingent consideration settled - warrants</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(108,000</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Contingent consideration, March 31, 2022</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,125,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="TEXT-INDENT: 15px;vertical-align:top;">Change in fair value (gain) reported in the consolidated statement of operations</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(666,000</strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td style="TEXT-INDENT: 15px;vertical-align:top;">Contingent consideration settled - cash</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(79,000</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Contingent consideration, June 30, 2022</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>380,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="TEXT-INDENT: 15px;vertical-align:top;">Change in fair value (loss) reported in the consolidated statement of operations</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>7,000</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Contingent consideration, September 30, 2022</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 2pt double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 2pt double;width:9%;vertical-align:bottom;text-align:right;"><strong>387,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q1	wyy	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Warrants Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWarrantsSettlements	-108000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1125000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-666000	usd
CY2022Q2	wyy	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cash Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashSettlements	-79000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	380000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	7000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	387000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1705000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-301000	usd
CY2022Q1	wyy	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cash Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCashSettlements	-171000	usd
CY2022Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	13600425	usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	12599572	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	41313	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	62988	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	13559112	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	12536584	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	541798	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	590065	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1241641	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1307548	usd
CY2022Q3	wyy	Qualified Payroll Credit Receivable QualifiedPayrollCreditReceivable	1144365	usd
CY2021Q4	wyy	Qualified Payroll Credit Receivable QualifiedPayrollCreditReceivable	1296396	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2927804	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3194009	usd
CY2022Q3	wyy	Accrued Service Costs Current AccruedServiceCostsCurrent	5387210	usd
CY2021Q4	wyy	Accrued Service Costs Current AccruedServiceCostsCurrent	8771660	usd
CY2022Q3	wyy	Salaries And Payroll Taxes SalariesAndPayrollTaxes	2099958	usd
CY2021Q4	wyy	Salaries And Payroll Taxes SalariesAndPayrollTaxes	2213356	usd
CY2022Q3	wyy	Inventory Purchases Consultants And Other Costscurrent InventoryPurchasesConsultantsAndOtherCostscurrent	1042920	usd
CY2021Q4	wyy	Inventory Purchases Consultants And Other Costscurrent InventoryPurchasesConsultantsAndOtherCostscurrent	1345900	usd
CY2022Q3	wyy	Us Income Tax Payable USIncomeTaxPayable	0	usd
CY2021Q4	wyy	Us Income Tax Payable USIncomeTaxPayable	-23562	usd
CY2022Q3	wyy	Accrued Other Expense Current AccruedOtherExpenseCurrent	18308	usd
CY2021Q4	wyy	Accrued Other Expense Current AccruedOtherExpenseCurrent	37072	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8548396	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12344426	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3953920	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3590665	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2891306	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2749532	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1062614	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	841133	usd
CY2022Q3	wyy	Depreciation1 Depreciation1	102000	usd
	wyy	Depreciation1 Depreciation1	305100	usd
CY2021Q3	wyy	Depreciation1 Depreciation1	89200	usd
	wyy	Depreciation1 Depreciation1	248900	usd
CY2021Q4	us-gaap	Goodwill Goodwill	22088578	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	16277000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	5811578	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	16300000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10750304	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-4112557	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6637747	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9433257	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3204371	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6228886	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	130000	usd
CY2022Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	316900	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1980000	usd
CY2021Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	133800	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	958400	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	373100	usd
CY2022Q3	wyy	Weighted Average Number Of Common Shares WeightedAverageNumberOfCommonShares	8725476	shares
CY2021Q3	wyy	Weighted Average Number Of Common Shares WeightedAverageNumberOfCommonShares	9129406	shares
	wyy	Weighted Average Number Of Common Shares WeightedAverageNumberOfCommonShares	8734471	shares
	wyy	Schedule Of Estimated Annual Amortization Of Intangible Assetstabletextblock ScheduleOfEstimatedAnnualAmortizationOfIntangibleAssetstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Remainder of 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">396,224</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,504,122</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,285,557</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">716,824</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">511,170</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,223,850</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 15px; text-align:left;">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-TOP: medium none; BORDER-BOTTOM: 2pt double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-TOP: medium none; BORDER-BOTTOM: 2pt double;width:9%;vertical-align:bottom;text-align:right;">6,637,747</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	396224	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1504122	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1285557	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	716824	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	511170	usd
CY2022Q3	wyy	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	2223850	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6637747	usd
	wyy	Net Paid Percentage NetPaidPercentage	0.90	pure
CY2022Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	700000.0	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	34400000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	38400000	usd
	wyy	Deferred Tax Assets DeferredTaxAssets	0.50	pure
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8725476	shares
	wyy	Proceeds From Issuance Of Stock Options ProceedsFromIssuanceOfStockOptions	41500	usd
	wyy	Proceeds From Stock Options Exercised1 ProceedsFromStockOptionsExercised1	179233	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	115141	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	235469	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	384267	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	662132	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	424800	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-540883	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	534884	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14692989	usd
	us-gaap	Net Income Loss NetIncomeLoss	915577	usd
CY2022Q3	wyy	Recognition Of Deferred Revenues RecognitionOfDeferredRevenues	25303516	usd
	wyy	Weighted Average Number Of Common Shares WeightedAverageNumberOfCommonShares	9066088	shares
CY2021Q3	wyy	Earnings Per Share Basic1 EarningsPerShareBasic1	-0.06
CY2022Q3	wyy	Earnings Per Share Basic1 EarningsPerShareBasic1	-0.06
	wyy	Earnings Per Share Basic1 EarningsPerShareBasic1	-1.68
	wyy	Earnings Per Share Basic1 EarningsPerShareBasic1	0.10
CY2022Q3	wyy	Net Loss Income Diluted NetLossIncomeDiluted	-540883	usd
CY2021Q3	wyy	Net Loss Income Diluted NetLossIncomeDiluted	534884	usd
	wyy	Net Loss Income Diluted NetLossIncomeDiluted	-14692989	usd
	wyy	Net Loss Income Diluted NetLossIncomeDiluted	915577	usd
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8725476	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9129406	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8734471	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9066088	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	28990	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	116102	shares
CY2022Q3	wyy	Adjustments Weighted Average Number Of Common Shares AdjustmentsWeightedAverageNumberOfCommonShares	8725476	shares
CY2021Q3	wyy	Adjustments Weighted Average Number Of Common Shares AdjustmentsWeightedAverageNumberOfCommonShares	9158396	shares
	wyy	Adjustments Weighted Average Number Of Common Shares AdjustmentsWeightedAverageNumberOfCommonShares	8734471	shares
	wyy	Adjustments Weighted Average Number Of Common Shares AdjustmentsWeightedAverageNumberOfCommonShares	9182190	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2022Q3	wyy	Revenues1 Revenues1	25303516	usd
CY2021Q3	wyy	Revenues1 Revenues1	22251282	usd
	wyy	Revenues1 Revenues1	70797297	usd
	wyy	Revenues1 Revenues1	62885545	usd
CY2022Q3	wyy	Revenues1 Revenues1	25303516	usd
CY2021Q3	wyy	Revenues1 Revenues1	22251282	usd
	wyy	Revenues1 Revenues1	70797297	usd
	wyy	Revenues1 Revenues1	62885545	usd
CY2021Q3	wyy	Recognition Of Deferred Revenues RecognitionOfDeferredRevenues	22251282	usd
	wyy	Recognition Of Deferred Revenues RecognitionOfDeferredRevenues	70797297	usd
	wyy	Recognition Of Deferred Revenue1 RecognitionOfDeferredRevenue1	344700	usd
	wyy	Revenue Related Approximately RevenueRelatedApproximately	2100000	usd
	wyy	Revenue Related Approximately RevenueRelatedApproximately	1800000	usd
	wyy	Recognition Of Deferred Revenues RecognitionOfDeferredRevenues	62885545	usd
	wyy	Recognition Of Deferred Revenue1 RecognitionOfDeferredRevenue1	485400	usd

Files In Submission

Name	View Source	Status
0001654954-22-015266-index-headers.html	Edgar Link	pending
0001654954-22-015266-index.html	Edgar Link	pending
0001654954-22-015266.txt	Edgar Link	pending
0001654954-22-015266-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wyy-20220930.xsd	Edgar Link	pending
wyy_10q.htm	Edgar Link	pending
wyy_ex311.htm	Edgar Link	pending
wyy_ex312.htm	Edgar Link	pending
wyy_ex32.htm	Edgar Link	pending
wyy-20220930_def.xml	Edgar Link	unprocessable
wyy-20220930_pre.xml	Edgar Link	unprocessable
wyy-20220930_lab.xml	Edgar Link	unprocessable
wyy_10q_htm.xml	Edgar Link	completed
wyy-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WYY
WIDEPOINT CORP Stock $wyy

2022 Q4 Form 10-Q Financial Statement

#000165495422015266 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYY WIDEPOINT CORP Stock $wyy

2022 Q4 Form 10-Q Financial Statement

#000165495422015266 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYY
WIDEPOINT CORP Stock $wyy